Figure 3
From: TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays

Covariate-adjusted survival curves for time to relapse in the NTUH (A) and METABRIC (B) cohorts.
From: TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
Covariate-adjusted survival curves for time to relapse in the NTUH (A) and METABRIC (B) cohorts.